THE INSULIN-LIKE GROWTH FACTORS (IGFs) play a critical role in both acute and chronic vascular injury responses through their potent effects on smooth muscle cell (SMC) proliferation, migration, and survival within the developing intimal lesion (5, 14) . IGF binding proteins (IGFBPs) produced by vascular cells modulate local IGF bioactivity through their control of IGF interaction with cognate receptors (16, 18, 19) . In vitro studies (6, 27) have implicated the inhibitory IGFBP-4 and a metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A), in cellular response to vascular injury. Proteolytic cleavage of IGFBP-4 by PAPP-A increases the pericellular IGF available for receptor activation (10, 13, 34) . In vivo, PAPP-A expression is induced in injured pig coronary arteries paralleling the formation of neointima (6) . Furthermore, strong PAPP-A immunoreactivity was demonstrated in culprit atherosclerotic plaques of humans who had died of myocardial infarction, with the most intense staining observed in the inflammatory shoulder in association with SMCs and macrophages (4) . Elevated levels of circulating PAPP-A have been demonstrated to be a potentially valuable marker of acute coronary syndromes (4, 20, 32) .
PAPP-A is expressed by vascular SMCs in culture (6) . However, little is known about the regulation of PAPP-A gene expression in these cells. In this study, we demonstrate that proinflammatory cytokines, known to be involved in neointimal hyperplasia and atherosclerosis, are potent stimulators of PAPP-A expression and, hence, proteolytic activity against IGFBP-4 in primary human coronary artery smooth muscle cells (hCASMCs). Interestingly, this effect was blocked by resveratrol, a naturally occurring compound found in the skin of grapes and in red wine.
MATERIALS AND METHODS

Materials. Tumor necrosis factor (TNF)-␣ and interleukin (IL)-1␤
were obtained from Research Diagnostics (Flanders, NJ). IGF-I was provided by Dr. Martin Spencer (San Francisco, CA). Resveratrol and actinomycin D were obtained from Sigma-Aldrich (St. Louis, MO), and reagents for SDS-PAGE were from Bio-Rad Laboratories (Richmond, CA).
Cell culture and RNA preparation. hCASMCs were obtained from Clonetics (Walkersville, MD) and cultured in smooth muscle growth medium containing 5% fetal bovine serum (FBS) as described previously (6) . Cells of the fourth to sixth passage were used for experiments. The cells were washed twice, preincubated overnight in medium containing 0.2% FBS, and then washed again and changed to 0.2% FBS with the indicated experimental additions. At the end of the incubation, conditioned medium was collected, centrifuged to remove debris, and stored at Ϫ70°C. Cell numbers were determined with the use of a Coulter Counter (Coulter Electronics, Hialeah, FL). Alternatively, total RNA was extracted from cells with the use of the RNeasy Mini Kit (Qiagen, Valencia, CA) and treated with DNase (DNA-free; Ambion, Austin, TX). Four hundred nanograms of RNA were reverse transcribed with the use of TaqMan RT reagents (PE Biosystems, Foster City, CA) according to manufacturer's instructions.
Real-time PCR. Real-time quantitative PCR analyses were performed using the ABI PRISM 7700 Sequence Detection System and software (PE Applied Biosystems). Primer and probe sequences for specific detection and amplification of PAPP-A, the precursor form of major basic protein (proMBP), and 28S were described previously (12, 37) . Relative mRNA abundance was calculated using the 2 Ϫ⌬⌬CT method (30) .
PAPP-A ELISA. PAPP-A levels in cell-conditioned medium were measured with the use of an Ultra-Sensitive PAPP-A ELISA kit (Diagnostic Systems Laboratories, Webster, TX). Minimum sensitivity was 0.24 mIU/l with intra-and interassay variation coefficients of 4.7% and 4.2%, respectively.
IGFBP-4 ELISA. IGFBP-4 levels in cell-conditioned medium were measured with the use of an IGFBP-4 ELISA kit from Diagnostic Systems Laboratories. Minimum sensitivity is 1 ng/ml, with intra-and interassay coefficients of variation of 2.8 -6.4% and 2.3-6.7%, respectively. This assay recognizes both intact and proteolytically cleaved human IGFBP-4.
Protease assay. Cell-free IGFBP-4 proteolysis was assayed as previously described (6, 12, 13, 27, 37) . Conditioned medium was incubated at 37°C for 2 h with 125 I-IGFBP-4 and 5 nM IGF-II. IGF-II binds IGFBP-4 and increases its susceptibility to cleavage by PAPP-A in vitro (35) . Reaction products were separated by SDS-PAGE and visualized by autoradiography. Extent of proteolysis, i.e., loss of intact and generation of 18-kDa radiolabeled fragments, was determined using enhanced laser densitometry (LKB Ultroscan XL).
Statistical analyses. Data are presented as means Ϯ SE. Statistical analyses were performed using ANOVA, followed by multiple comparisons. Results were considered statistically significant at P Ͻ 0.05, and were replicated in independent experiments.
RESULTS
Cytokine stimulation of PAPP-A expression.
TNF-␣ and IL-1␤ were chosen to study the effects of proinflammatory cytokines on PAPP-A expression in cultured hCASMC. Dosedependent increases in PAPP-A levels in hCASMC-conditioned medium were seen after treatment of cells with TNF-␣ and IL-1␤ for 24 h (Fig. 1 ). TNF-␣ showed half-maximal effectiveness at 1 pM, with maximal effectiveness (threefold) at 10 pM. IL-1␤ showed half-maximal effectiveness at ϳ0.01 pM, with maximal effectiveness (fourfold) at 1 pM. A timecourse experiment of TNF-␣-and IL-1␤-stimulated PAPP-A mRNA expression in hCASMC indicated significant increases at 4 h and peak expression (15-to 25-fold elevated relative to control) at 8 h, with elevated expression (3 to 5 fold) retained at 24 h (Fig. 2) . The effect of these proinflammatory cytokines appears to be at the level of transcription, as the RNA poly- merase inhibitor, actinomycin D, completely prevented TNF-␣ and IL-1␤ induction of PAPP-A gene expression (Fig. 3) . Treatment of hCASMC with these cytokines had no significant effect on total (intact and fragmented) IGFBP-4 levels ( Table 1) .
Resveratrol inhibition of PAPP-A expression. Resveratrol, a polyphenol abundantly present in the skin of grapes and in red wine, is a promising cardiovascular system-protective agent (8, 39, 42, 44) . We found that pretreatment of hCASMC with resveratrol at 30 M, a dose determined to be maximally effective in initial experiments, markedly inhibited TNF-␣-and IL-1␤-stimulated PAPP-A mRNA synthesis (Fig. 4A ) and protein expression (Fig. 4B) . Resveratrol had no significant effect on basal PAPP-A expression. Resveratrol had no significant effect on cell number in these experiments (Table 2) .
IGFBP-4 proteolysis. To substantiate that the changes in PAPP-A expression regulated by cytokines and resveratrol correlate with changes in proteolytic activity, we assessed proteolytic activity against 125 I-labeled IGFBP-4 in cell-conditioned medium (Fig. 5) . In a cell-free assay, conditioned medium from hCASMC exhibited basal IGFBP-4 protease activity (lane b), as previously reported (6) . However, medium from cells treated with TNF-␣ (lane d) and IL-1␤ (lane f) showed enhancement of proteolytic activity against IGFBP-4. In three separate experiments, cytokine-stimulated protease activity was two-to threefold that of basal activity. Importantly, the cytokine-stimulated increase in activity was inhibited by resveratrol treatment of the cells (lanes e and g) without any effect on the basal level of IGFBP-4 proteolytic activity (lane c).
DISCUSSION
The data presented here demonstrate that PAPP-A gene expression in hCASMC is stimulated by proinflammatory cytokines and suggest a mechanism for the regulation of PAPP-A in response to vascular injury that may contribute to the enhanced IGF-I bioactivity in intimal hyperplasia and atherosclerotic plaque development. Furthermore, resveratrol, currently under investigation for its potential antioxidant and cardioprotective properties (8, 39, 42, 44) , was able to block cytokine-stimulated PAPP-A expression.
It is well established that IGFs and cytokines are critically involved in the vascular response to acute and chronic injury (5, 14, 24, 38) , but there has been little investigation into a possible relationship between these two systems. The proinflammatory cytokines TNF-␣ and IL-1␤ have both been implicated in the regulation of atherosclerotic plaque development and stability. Thus, our finding that TNF-␣ and IL-1␤ stimulate hCASMC synthesis of PAPP-A is an important linkage because PAPP-A cleaves the inhibitory IGFBP-4, resulting in increased local IGF-I bioavailability and receptor signaling (10, 13, 34) . We observed a log difference in dose effectiveness between the two cytokines (IL-1␤ Ͼ TNF-␣), but they showed very similar stimulation kinetics with an increase in PAPP-A mRNA expression at 4 h that peaked ϳ8 h and continued to be elevated relative to controls 24 h poststimulation. The increases in PAPP-A levels in the cell-conditioned medium reflected the large increase in PAPP-A mRNA synthesis. Because the stimulation of PAPP-A expression was blocked by actinomycin D, the effects of TNF-␣ and IL-1␤ appear to be at level of transcription.
Receptors recognizing and responding to TNF-␣ and IL-1␤ are present on vascular SMC (23, 24) . This is the first report to demonstrate marked increases in SMC expression of PAPP-A, a metalloprotease in the metzincin superfamily (7), on treatment with these cytokines. Several members of the matrix metalloproteinase family, which also belongs to the metzincin superfamily, have been implicated in plaque development and instability through their functional role in degrading extracellular matrix components (15, 17, 29, 31, 36, 41) . PAPP-A has not been associated with matrix degradation in vivo or in vitro, but rather exclusively with specific cleavage of IGFBPs (25) . However, we cannot exclude the possibility that PAPP-A has other substrates.
Resveratrol is naturally found at high concentrations in grapes and derived products, such as red wine, and it has been proposed that this compound is the cardioprotective agent behind the "French paradox" (8, 39, 42, 44) . Resveratrol possesses many biological activities that favor protection against atherosclerosis, including inhibition of vascular SMC proliferation (2, 22, 33) . In this study, we show that resveratrol blocks cytokine-stimulated PAPP-A expression in hCASMC without affecting basal expression. The decrease in measured protease activity on treatment of cells with resveratrol paralleled the decrease in PAPP-A mRNA and protein levels, suggesting a direct effect of resveratrol on PAPP-A expression. The observed decrease in proteolytic activity was not due to an induction of proMBP (data not shown), a physiological inhibitor of PAPP-A, which in other studies has been shown to account for a decrease in IGFBP-4 protease activity on treatment of human fibroblasts with phorbol ester tumor promoters (12) . Several studies investigating the cellular mechanism of resveratrol have shown a reduction in the activation of NF-B (21, 43), a transcription factor that is involved in mediating oxidative stress, which is upregulated in atherosclerosis (9, 11, 28) . TNF-␣-induced human vascular SMC proliferation is mediated by NF-B (40) . TNF-␣ and IL-1␤ also activated NF-B in hCASMC, but this activation was not affected by resveratrol (data not shown). Further studies will be necessary to determine the mechanism by which resveratrol inhibits cytokine-induced PAPP-A expression.
The data presented here are consistent with a proposed model in which an increase in PAPP-A expression stimulated by proinflammatory cytokines, such as TNF-␣ and IL-1␤, amplifies the vascular response to IGFs through PAPP-Ainduced cleavage of IGFBP-4 (Fig. 6) . The most abundant IGFBP in the vascular wall is IGFBP-4, which is secreted by vascular SMC. Intact IGFBP-4 binds IGF-I, forming a pericellular reservoir of this potent growth factor. Vascular SMCs have receptors for IGF-I and respond to IGF-I with increased signaling leading to proliferation, migration, and extracellular matrix production. However, under the conditions depicted in (26) and, consequently, increased local IGF. IGF-I receptor activation during response to injury results in increased proliferation, migration, and matrix production (Fig. 6B) . This model could apply to acute injury to the vasculature, such as in restenosis after balloon angioplasty and stenting, as well as to chronic injury, such as in atherosclerosis. In addition, possible cytokine-modulated changes in IGF-I, IGF-I receptor, and/or IGFBP expression in vascular SMC (1, 45) may be relevant to this model.
Our results further suggest that the cardioprotective effects of resveratrol may, in part, be caused by its blocking of cytokine-stimulated PAPP-A expression, although such a model awaits direct testing in vivo. A further increase in our understanding of the mechanism of cytokine regulation of IGF bioavailability in general and PAPP-A expression in particular may lead to novel therapeutic targets for intimal hyperplasia and atherosclerosis.
